Physician profile
Kayla Walker
NPI 1881103448
$914.47
in general payments reported to CMS, 2019-2025
10 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $161 · 2024: $160 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.86 | 2022-2025 | |
| Lilly USA, LLC | $223.74 | 2022-2025 | Mounjaro, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.05 | 2025 | Caplyta |
| Allergan, INC. | $105.65 | 2021 | |
| Novo Nordisk INC | $47.79 | 2025 | Wegovy, Ozempic, Rybelsus |
| Phadia US INC. | $28.17 | 2025 | Immunocap |
| Boston Scientific Corporation | $27.38 | 2025 | Axonics |
| Dexcom, INC. | $23.59 | 2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $16.12 | 2025 | Airsupra |
| Axonics, INC. | $14.12 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.